Deyaa Adib - Apr 22, 2024 Form 3 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Michael Hom, Attorney-in-Fact
Stock symbol
FGEN
Transactions as of
Apr 22, 2024
Transactions value $
$0
Form type
3
Date filed
4/24/2024, 04:15 PM
Next filing
Jun 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FGEN Common Stock 60K Apr 22, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FGEN Stock Option (Right to Buy) Apr 22, 2024 Common Stock 300K $1.71 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 11, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
F2 Twenty-five percent of the shares subject to the option will vest on March 11, 2025, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.